Full safety information, provider consultation requirements, and restrictions, are available at Midis mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story
ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article
REDEFINE 1 demonstrated 20.4% weight loss with 60% of patients achieving 20%+ reduction, substantially exceeding semaglutide alone
Multi-peptide blend (GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg), lyophilised powder for laboratory research into combined peptide signalling pathways
These compounds work by blocking damaging pathways, clearing senescent cells, and activating RXFP1 receptors to limit scarring